Functional Angioplasty: Definitions, Historical Overview, and Future Perspectives

Hanbit Park1, Do-Yoon Kang2, Cheol Whan Lee3

  • 1Division of Cardiology, Department of Medicine, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea.

Insights

Percutaneous coronary intervention (PCI) for stable coronary artery disease (CAD) may relieve angina but not improve prognosis. Complete revascularization (CR) of ischemia-causing lesions may improve outcomes, but definitions of inducible myocardial ischemia lack standardization.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • Percutaneous coronary intervention (PCI) is a common treatment for obstructive coronary artery disease (CAD).
  • While its role in acute coronary syndromes is clear, its benefit in stable CAD, particularly regarding prognosis, remains debated.
  • PCI often alleviates angina symptoms but may not alter long-term outcomes.

Purpose of the Study:

  • To review the current understanding of myocardial ischemia in stable CAD.
  • To evaluate the evidence supporting PCI guidance and complete revascularization (CR).
  • To discuss challenges in defining inducible myocardial ischemia and propose ideal definitions and PCI strategies.

Main Methods:

  • Review of existing studies on myocardial ischemia, PCI, and revascularization strategies.
  • Analysis of diagnostic tools for assessing inducible myocardial ischemia.
  • Discussion of clinical relevance of ischemia hallmarks like ECG changes and wall motion abnormalities.

Main Results:

  • Complete revascularization (CR) of all ischemia-causing lesions may be associated with better outcomes compared to incomplete revascularization.
  • Inconsistent definitions of inducible myocardial ischemia across studies hinder direct comparisons.
  • No universally agreed-upon reference standard exists for diagnosing inducible myocardial ischemia.

Conclusions:

  • Standardizing the definition of inducible myocardial ischemia is crucial for comparing study outcomes.
  • Clinically relevant ischemia hallmarks may serve as a reference standard.
  • Optimizing PCI strategy based on a clear definition of ischemia is essential for improving patient prognosis in stable CAD.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
46
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
59
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
46
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
44
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.0K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.8K